For the third consecutive year, Noventure has participated in the annual congress of the EAU - European Association of Urology that took place in Copenhagen 17th – 19th March 2018 with about 11,000 participants, coming from 123 countries all over the world. During the Congress 273 scientific sessions included 2,656 presentations of cutting-edge urological updates presented by 1,830 international experts.
Noventure participated in this congress with a 28 m2 stand to assess its presence in the urology field thanks to its medical device UTIPRO PLUS intended to control and prevent uncomplicated UTIs.
Noventure’s team received urologists from all over the world at its stand and answered to all queries on the product and on its current and future availability all over Europe.
At the stand there were also the welcome presence of the General Manager and the Marketing Manager of Zambon Italia who reinforced their links with Italian KOLs, the CEO and the Marketing Manager of ELVA, the Company which recently successfully launched the product in Hungary and in the Czech and Slovak Republics, and the Marketing Team from RFSU, the Swedish Company which entered into agreement with Noventure to distribute the product in 5 Nordic Countries.
Since its first launch in June 2014, UTIPRO PLUS is now in 18 EU Countries with 11 different partners under 5 brands and, thanks to already signed contracts, before the EAU congress in Barcelona next year, UTIPRO PLUS is expected to be in 23 Countries across Europe.
Utipro® Plus is a class III medical device and complies with the Essential Requirements of Directive 93/42/EEC and subsequent amendments. (CE 0373, Noventure SL)
In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.
Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.